These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36277370)

  • 1. Role of integrin α2 in methotrexate-induced epithelial-mesenchymal transition in alveolar epithelial A549 cells.
    Kawami M; Ojima T; Yumoto R; Takano M
    Toxicol Res; 2022 Oct; 38(4):449-458. PubMed ID: 36277370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of plasminogen activator inhibitor-1 in methotrexate-induced epithelial-mesenchymal transition in alveolar epithelial A549 cells.
    Yamagami Y; Kawami M; Ojima T; Futatsugi S; Yumoto R; Takano M
    Biochem Biophys Res Commun; 2020 May; 525(3):543-548. PubMed ID: 32113686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate-Induced Epithelial-Mesenchymal Transition in the Alveolar Epithelial Cell Line A549.
    Kawami M; Harabayashi R; Miyamoto M; Harada R; Yumoto R; Takano M
    Lung; 2016 Dec; 194(6):923-930. PubMed ID: 27604426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Nrf2 in Methotrexate-Induced Epithelial-Mesenchymal Transition in Alveolar A549 Cells.
    Kawami M; Honda M; Hara T; Yumoto R; Takano M
    Biol Pharm Bull; 2022; 45(8):1069-1076. PubMed ID: 35908888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid prevents methotrexate-induced epithelial-mesenchymal transition via suppression of secreted factors from the human alveolar epithelial cell line A549.
    Kawami M; Harabayashi R; Harada R; Yamagami Y; Yumoto R; Takano M
    Biochem Biophys Res Commun; 2018 Feb; 497(1):457-463. PubMed ID: 29448106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential mechanisms underlying methotrexate-induced cell death and epithelial-mesenchymal transition in A549 cells.
    Ojima T; Kawami M; Yumoto R; Takano M
    Toxicol Res; 2021 Jul; 37(3):293-300. PubMed ID: 34295794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation on inhibitory effect of folic acid on methotrexate-induced epithelial-mesenchymal transition focusing on dihydrofolate reductase.
    Kawami M; Honda N; Hara T; Yumoto R; Takano M
    Drug Metab Pharmacokinet; 2019 Dec; 34(6):396-399. PubMed ID: 31601464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of epithelial-mesenchymal transition in methotrexate-induced pulmonary fibrosis.
    Ohbayashi M; Kubota S; Kawase A; Kohyama N; Kobayashi Y; Yamamoto T
    J Toxicol Sci; 2014 Apr; 39(2):319-30. PubMed ID: 24646714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Investigation of Drug-induced Lung Injury for the Development of a Novel Therapeutic Approach].
    Kawami M
    Yakugaku Zasshi; 2020; 140(1):15-22. PubMed ID: 31902879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of cell cycle arrest with anticancer drug-induced epithelial-mesenchymal transition in alveolar epithelial cells.
    Kawami M; Harada R; Ojima T; Yamagami Y; Yumoto R; Takano M
    Toxicology; 2019 Aug; 424():152231. PubMed ID: 31170432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer Drug-Induced Epithelial-Mesenchymal Transition via p53/miR-34a axis in A549/ABCA3 Cells.
    Yamamoto A; Kawami M; Konaka T; Takenaka S; Yumoto R; Takano M
    J Pharm Pharm Sci; 2019; 22(1):516-524. PubMed ID: 31603744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of TGF-β1- and drug-induced epithelial-mesenchymal transition in cultured alveolar epithelial cell line RLE/Abca3.
    Takano M; Yamamoto C; Yamaguchi K; Kawami M; Yumoto R
    Drug Metab Pharmacokinet; 2015 Feb; 30(1):111-8. PubMed ID: 25760538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT).
    Kasai H; Allen JT; Mason RM; Kamimura T; Zhang Z
    Respir Res; 2005 Jun; 6(1):56. PubMed ID: 15946381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-catenin induces A549 alveolar epithelial cell mesenchymal transition during pulmonary fibrosis.
    Song P; Zheng JX; Xu J; Liu JZ; Wu LY; Liu C
    Mol Med Rep; 2015 Apr; 11(4):2703-10. PubMed ID: 25435076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of miR-34a in TGF-β1- and Drug-Induced Epithelial-Mesenchymal Transition in Alveolar Type II Epithelial Cells.
    Takano M; Nekomoto C; Kawami M; Yumoto R
    J Pharm Sci; 2017 Sep; 106(9):2868-2872. PubMed ID: 28408209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nintedanib inhibits epithelial-mesenchymal transition in A549 alveolar epithelial cells through regulation of the TGF-β/Smad pathway.
    Ihara H; Mitsuishi Y; Kato M; Takahashi F; Tajima K; Hayashi T; Hidayat M; Winardi W; Wirawan A; Hayakawa D; Kanamori K; Matsumoto N; Yae T; Sato T; Sasaki S; Takamochi K; Suehara Y; Ogura D; Niwa SI; Suzuki K; Takahashi K
    Respir Investig; 2020 Jul; 58(4):275-284. PubMed ID: 32359980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation on epithelial-mesenchymal state and microRNAs focusing on isolated alveolar epithelial cells from bleomycin injured rat lung.
    Kawami M; Takenaka S; Kadekaru Y; Akai M; Konaka T; Yumoto R; Takano M
    Toxicology; 2021 Sep; 461():152903. PubMed ID: 34425168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteinase-activated receptor 4 stimulation-induced epithelial-mesenchymal transition in alveolar epithelial cells.
    Ando S; Otani H; Yagi Y; Kawai K; Araki H; Fukuhara S; Inagaki C
    Respir Res; 2007 Apr; 8(1):31. PubMed ID: 17433115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of miR-34a-Induced Epithelial-Mesenchymal Transition in Non-Small Lung Cancer Cells Focusing on p53.
    Kawami M; Takenaka S; Akai M; Yumoto R; Takano M
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of transforming growth factor-β1 on functional expression of monocarboxylate transporter 1 in alveolar epithelial A549 cells.
    Uddin M; Kawami M; Yumoto R; Takano M
    Naunyn Schmiedebergs Arch Pharmacol; 2020 May; 393(5):889-896. PubMed ID: 31900520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.